FI962976A - Viherkaihin hoitoon tarkoitettuja koostumuksia, jotka sisältävät beta-salpaajaa - Google Patents

Viherkaihin hoitoon tarkoitettuja koostumuksia, jotka sisältävät beta-salpaajaa Download PDF

Info

Publication number
FI962976A
FI962976A FI962976A FI962976A FI962976A FI 962976 A FI962976 A FI 962976A FI 962976 A FI962976 A FI 962976A FI 962976 A FI962976 A FI 962976A FI 962976 A FI962976 A FI 962976A
Authority
FI
Finland
Prior art keywords
blocker
beta
compositions
treatment
cataracts
Prior art date
Application number
FI962976A
Other languages
English (en)
Swedish (sv)
Other versions
FI962976A0 (fi
Inventor
Yusuf Ali
Rajni Jani
George R Mccarty
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of FI962976A0 publication Critical patent/FI962976A0/fi
Publication of FI962976A publication Critical patent/FI962976A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI962976A 1994-01-28 1996-07-26 Viherkaihin hoitoon tarkoitettuja koostumuksia, jotka sisältävät beta-salpaajaa FI962976A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18828494A 1994-01-28 1994-01-28
US08/334,512 US5554367A (en) 1984-10-31 1994-11-04 Compositions for treatment of glaucoma
PCT/US1995/001017 WO1995020378A1 (en) 1994-01-28 1995-01-24 Compositions for treatment of glaucoma comprising pilocarpine and a beta-blocker

Publications (2)

Publication Number Publication Date
FI962976A0 FI962976A0 (fi) 1996-07-26
FI962976A true FI962976A (fi) 1996-07-26

Family

ID=26883909

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962976A FI962976A (fi) 1994-01-28 1996-07-26 Viherkaihin hoitoon tarkoitettuja koostumuksia, jotka sisältävät beta-salpaajaa

Country Status (9)

Country Link
US (1) US5554367A (fi)
EP (1) EP0741563A1 (fi)
JP (1) JP2854418B2 (fi)
AU (1) AU688854B2 (fi)
CA (1) CA2181929C (fi)
FI (1) FI962976A (fi)
MX (1) MX9603060A (fi)
NO (1) NO963130L (fi)
WO (1) WO1995020378A1 (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2297894T3 (es) * 1997-11-05 2008-05-01 Senju Pharmaceutical Co., Ltd. Colirio de liberacion prolongada.
US6335335B2 (en) 1997-11-05 2002-01-01 Senju Pharmaceutical Co., Ltd. Prolonged-action eye drop
WO2000024425A1 (en) * 1998-10-27 2000-05-04 Alcon Laboratories, Inc. Preservative system for topically administrable pharmaceutical compositions
CN1245966C (zh) * 1999-11-30 2006-03-22 爱尔康公司 β－肾上腺素受体拮抗剂用于制备治疗外层视网膜疾病的药物的用途
TWI298257B (en) 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
US20050031652A1 (en) * 2003-02-25 2005-02-10 Allergan, Inc. Compositions and methods comprising memantine and polyanionic polymers
US20050147584A1 (en) * 2004-01-05 2005-07-07 Allergan, Inc. Compositions and methods comprising memantine and polyanionic polymers
US20050106321A1 (en) * 2003-11-14 2005-05-19 Molecular Imprints, Inc. Dispense geometery to achieve high-speed filling and throughput
US20050277698A1 (en) * 2004-01-05 2005-12-15 Hughes Patrick M Memantine delivery to the back of the eye
US20070077302A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for stabilizing ophthalmic compositions
CA2671613C (en) * 2006-12-05 2018-07-03 The Royal Institution For The Advancement Of Learning/Mcgill University Methods of use of trk receptor modulators
BR112012029461A2 (pt) * 2010-05-19 2017-03-01 Astellas Pharma Inc composição farmacêutica contendo solifenacina
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2330383A1 (fr) * 1975-11-06 1977-06-03 Synthelabo Nouveaux ethers de phenols substitues, leurs sels, leur preparation et les medicaments qui les renferment
US4342783A (en) * 1980-06-30 1982-08-03 Synthelabo Anti-glaucoma agent
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
US4911920A (en) * 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
FR2601247A1 (fr) * 1986-07-09 1988-01-15 Merk Sharp Dohme Chibret Labor Combinaison d'agents beta-bloquants et de pilocarpine.
US5182102A (en) * 1991-07-12 1993-01-26 Alcon Laboratories, Inc. Anti-glaucoma compositions
AU666957B2 (en) * 1992-08-28 1996-02-29 Alcon Laboratories, Inc. Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions

Also Published As

Publication number Publication date
FI962976A0 (fi) 1996-07-26
CA2181929A1 (en) 1995-08-03
NO963130D0 (no) 1996-07-26
MX9603060A (es) 1997-03-29
AU688854B2 (en) 1998-03-19
EP0741563A1 (en) 1996-11-13
JP2854418B2 (ja) 1999-02-03
WO1995020378A1 (en) 1995-08-03
US5554367A (en) 1996-09-10
NO963130L (no) 1996-07-26
AU1607495A (en) 1995-08-15
CA2181929C (en) 1998-11-03
JPH09505604A (ja) 1997-06-03

Similar Documents

Publication Publication Date Title
DE19581637T1 (de) Multifunktionelle, biologisch dispergierende/biozide Zusammensetzungen
DK0777671T3 (da) Spiro-azabicykliske forbindelser
DK0799297T3 (da) Fortykkede persyresammensætninger
CY2004003I2 (el) Παραγωγα 2-(2-αμινο-1, 6-διϋδρο-6-οξο-πυρινο-9-υλο)-μεθοδυ-1,3-προπανεδιολης
DK0799298T3 (da) Fortykkede persyresammensætninger
DK0820451T3 (da) Hidtil ukendte heterocykliske forbindelser
FI962976A (fi) Viherkaihin hoitoon tarkoitettuja koostumuksia, jotka sisältävät beta-salpaajaa
FI971674A0 (fi) Heterosyklisen ryhmän sisältämät di-tert-butyyli-fenoliyhdisteet, käyttökelpoisia tulehduksenvastaisina aineina
TR199501653A2 (tr) Silikonlu bilesimler.
FI941776A0 (fi) Menetelmä 1,2,4-tiadiatsolien valmistamiseksi
FI960367A (fi) Uusia dialkoksipyridinyylibentsimidatsolijohdannaisia
FI970151A0 (fi) Viruksenvastaisesti vaikuttavia difluoristatoniyhdisteitä
FI940992A0 (fi) Cylindergrupp med enkelt viradrag i torkningspartiet av en pappersmaskin och torkningsparti i pappersmaskin som innehaoller dessa
FI973644A0 (fi) Uusi menetelmä 2,3-dihydrobentsofuranolijohdannaisten valmistamiseksi
TR199501652A2 (tr) Silikonlu bilesimler.
KR960702835A (ko) 헤테로사이클릭 화학(Heterocyclic chemistry)
FI972624A (fi) 14alfa,17alfa-C2-sillan sisältäviä 19-norprogesteronijohdoksia
TR199501647A2 (tr) Silikonlu bilesimler.
ATE182133T1 (de) Naphtochinonderivate
FI972694A (fi) Uusi menetelmä sameridiinin valmistamiseksi
NO963208D0 (no) Anvendelse av 1,3,2-benzoditiazol-1-oksyder som mikrobiocider for beskyttelse av tekniske materialer såvel som visse 1,3,2-benzoditiazol-1-oksyder
BR9510036A (pt) Derivados de 1,3,4-oxadiazina
SE9402838D0 (sv) New compounds
SE9403728D0 (sv) New compounds
SE9402813D0 (sv) New compounds